1. Allen TM, Mehra T, Hansen C et al. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. Cancer Res 1992; 52(9)2431–2439.
2. Ellens H, Rustum Y, Mayhew E et al. Distribution and metabolism of liposome-encapsulated and free 1-beta-D-arabinofuranosylcytosine (Ara-C) in dog and mouse tissues. J Pharm Exp Therap 1982; 222 (2): 324–330.
3. Perez-Soler R, Francis K, Baker S et al. Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use. J Micro-encapsulation 1994; 11 [1]: 41–54.
4. Sharma A, Mayhew E, Straubinger RM. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. Cancer Res 1993; 53 (24): 5877–5881.
5. Baguley BC, Falkenhaug EM. Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia. Cancer Chemotherapy Rep 1971; 55 (3): 291–298.